CompletedPhase 3NCT00396682

Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma

Studying Cerebrotendinous xanthomatosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hannover Medical School
Principal Investigator
Tim F Greten, M.D., M.D
Department of Gastroenterology, Medizinische Hochschule Hannover
Intervention
Cyclophosphamide(drug)
Enrollment
12 enrolled
Eligibility
18 years · All sexes
Timeline
20072008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00396682 on ClinicalTrials.gov

Other trials for Cerebrotendinous xanthomatosis

Additional recruiting or active studies for the same condition.

See all trials for Cerebrotendinous xanthomatosis

← Back to all trials